Evidence map›Paper›PMID 41532517›Full record

SynthesisJournal of the American Heart Association2026

Cognitive Outcomes in Randomized Controlled Trials of Coronary Artery Bypass Graft Surgery From 2005 to 2025: A Systematic Review.

Shantanu Srivatsa, Sajeevan Sujanthan, Sydni Paleczny, David A Ripsman, Stephanie Niño de Rivera, Arnaldo Dimagli, Foad Taghdiri, Pai-Shan Cheng, Wendy Lou, Michael E Farkouh and 7 more

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shantanu Srivatsa *Department of Medicine University of North Carolina School of Medicine Chapel Hill North Carolina USA.ORCID 0000-0002-9398-8358
Sajeevan Sujanthan *Department of Medicine (Neurology) Hurvitz Brain Sciences Program, Sunnybrook HSC, Institute of Medical Sciences, University of Toronto Toronto Ontario Canada.ORCID 0000-0002-3128-3977
Sydni PalecznyDepartment of Neuroscience Schulich School of Medicine and Dentistry, Western University London Ontario Canada.ORCID 0009-0005-1443-6563
David A RipsmanDepartment of Medicine (Neurology) University of British Columbia Vancouver British Columbia Canada.ORCID 0000-0002-2839-2240
Stephanie Niño de RiveraColumbia University School of Nursing, Columbia University Irving Medical Center New York NY USA.
Arnaldo DimagliDepartment of Surgery Columbia University Irving Medical Center New York NY USA.
Foad TaghdiriDivision of Neurology, Department of medicine University of Toronto Toronto Ontario Canada.ORCID 0000-0002-3280-2804
Pai-Shan ChengBiostatistics Division Dalla Lana School of Public Health, University of Toronto Toronto Ontario Canada.ORCID 0009-0008-5900-2920
Wendy LouDalla Lana School of Public Health University of Toronto Toronto Ontario Canada.
Michael E FarkouhAcademic Affairs, Cedars-Sinai Health System Los Angeles CA USA.ORCID 0000-0002-8095-0246
Stephen E FremesDivision of Cardiac Surgery, Schulich Heart Centre, Sunnybrook HSC, Department of Surgery Institute of Medical Sciences, Institute of Health Policy Management and Evaluation, University of Toronto Toronto Ontario Canada.ORCID 0000-0003-1723-3049
Mario Fl GaudinoDepartment of Cardio-thoracic Surgery Cornell Medicine New York NY USA.ORCID 0000-0003-4680-0815
Jennifer RabinDepartment of Medicine (Neurology) Hurvitz Brain Sciences Program, Sunnybrook HSC, Institute of Medical Sciences, University of Toronto Toronto Ontario Canada.ORCID 0000-0003-4754-2221
Louai RazzoukDepartment of Interventional Cardiology, Leon H. Charney Division of Cardiology New York University Grossman School of Medicine New York NY USA.ORCID 0000-0002-0306-6182
Adrian M OwenDepartment of Physiology and Pharmacology and Department of Psychology Western University London Ontario Canada.ORCID 0000-0002-5738-3765
Ruth Masterson CreberColumbia University School of Nursing, Columbia University Irving Medical Center New York NY USA.ORCID 0000-0002-4238-9902
Richard H SwartzDepartment of Medicine (Neurology) Hurvitz Brain Sciences Program, Sunnybrook HSC, Institute of Medical Sciences, University of Toronto Toronto Ontario Canada.ORCID 0000-0001-6571-5531

Funding

Cardiovascular Epidemiology Training GrantT32HL007055 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Wayne D. Rosamond · 1986 to 2026
$10.0M
NHLBI NIH HHS T32 HL007055
6 · The paper itself

Abstract

backgroundCognitive decline after coronary artery bypass graft (CABG) is common and affects morbidity, mortality, and quality of life. We systematically reviewed randomized CABG trial control arms to characterize cognitive assessments, testing frequency, attrition, and ability to detect perioperative change.

methodsWe searched MEDLINE, Embase, Cochrane Library, and PsycINFO for randomized controlled trials of CABG surgery that included at least one arm of patients solely undergoing CABG and that reported at least one objective cognitive assessment, from January 2005 to February 2025. Trials with mixed cardiac surgery or only subjective measures were excluded. We summarized task frequency, cognitive domains, and attrition. For tasks assessed preoperatively and postoperatively in ≥3 trials, we reported control group means and SDs. Risk of bias was assessed using the Cochrane Risk of Bias tool among 6 bias domains. This study was supported by NIH-R01NS123639.

resultsOf 3494 screened studies, 2284 were CABG trials, and only 71 (3.1%) reported cognitive evaluation. These involved 15 925 patients (79% men; mean age, 64.2 years; median follow-up, 90 days) and used 145 unique cognitive tasks, with the Trail Making Test Part B (40 of 71; 56.3%) and Part A (38 of 71; 53.5%) being the most frequently administered. Among 7 tasks with sufficient data, none detected preoperative to postoperative changes. Attrition rates averaged 18.9%, with a broad range of 0 to 62%.

conclusionsCognitive assessment is uncommon in CABG trials, and commonly used tests rarely detect change. Heterogeneity precluded meta-analysis, and high attrition raises concerns about selection and survivorship bias. To evaluate cognitive impact after CABG, trials need standardized, sensitive assessment strategies resilient to attrition and feasible for broad deployment.

Indexed as

CognitionCognitive DysfunctionCoronary Artery BypassPostoperative Cognitive ComplicationsHumansRandomized Controlled Trials as TopicTreatment OutcomeCABGcognitioncognitive impairmentrandomized controlled trialsurgery

Identifiers

PMID41532517
PMCPMC12919493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.